The historic rise of Viagra has firmly established as a example of pharmaceutical success, yet its legacy within the broader sector now presents questions about future yields . Copycat versions are diminishing market share, prompting anxieties that betting on companies heavily reliant to Viagra's former standing could be a dangerous move , especial